As research about the impacts of GLP-1s on addiction continues, one thing should be made clear to the public: GLP-1s are currently not FDA-approved to treat SUD
Four states dropped coverage in late 2025: California, New Hampshire, Pennsylvania , and South Carolina all eliminated Medicaid coverage of GLP-1s for obesity treatment reducing the national count from 16 states to 13
Sermorelin works by stimulating the bodys own hormone production while preserving the natural feedback loop between the brain and pituitary gland, a mechanism often preferred for long-term hormonal support
No pattern of medication errors, unlicensed prescribing, or dispensing violations appears in publicly available regulatory databases at the time of this review
Using the Writing to your doctor page will help you to educate your doctor and you can also access personalised help for tailored support with this
lactis MG1363-pMG36e-GLP-1 plays a neurotrophic role in Parkinsons disease through the regulation of oxidative stress, prevention of ferroptosis, and correction of dysbiosis [104]
